The firm has raised $78 million to date and is launching its first clinical trial to test a treatment for ...

The firm also said it completed enrollment in the Phase III 4FRONT-2 clinical trial of 4D-150 in wet AMD ahead of schedule.

The company is planning to test its oral immunotherapy in over 800 patients with resectable and unresectable tumors.

The European Commission on Monday approved AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) as a tissue-agnostic treatment for previously treated patients with unresectable or ...

During its research day, the firm discussed a cell therapy effort in lupus, dubbed "007," and an AI platform for gleaning ...

The program will help make genetic counselors available to any provider across different medical specialties in Tennessee and ...

Three cases suggest some clinicians lack understanding of relatively common autosomal recessive disorders and are ...

The firm submitted applications based on data from the Phase III NIMBLE trial, in which cemdisiran improved patients' ability to do daily tasks.

The combined company will focus on the development and commercialization of SERP-01 for the treatment of severe AATD.

The positive decision is based on results from a Phase III study evaluating first-line Datroway against chemotherapy.

In a clinical trial, Redemplo led to a median 80 percent decrease in fasting triglyceride levels from baseline.

The CAR-T maker will finance a second year of grants, educational resources, and surveying for patients and caregivers.